These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 34476509)

  • 21. Reversal of acquired resistance to doxorubicin in K562 human leukemia cells by astemizole.
    Ishikawa M; Fujita R; Takayanagi M; Takayanagi Y; Sasaki K
    Biol Pharm Bull; 2000 Jan; 23(1):112-5. PubMed ID: 10706423
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Targeting P-glycoprotein expression and cancer cell energy metabolism: combination of metformin and 2-deoxyglucose reverses the multidrug resistance of K562/Dox cells to doxorubicin.
    Xue C; Wang C; Liu Q; Meng Q; Sun H; Huo X; Ma X; Liu Z; Ma X; Peng J; Liu K
    Tumour Biol; 2016 Jul; 37(7):8587-97. PubMed ID: 26733176
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Pharmacological Strategy Using Stemofoline for more Efficacious Chemotherapeutic Treatments Against Human Multidrug Resistant Leukemic Cells.
    Umsumarng S; Mapoung S; Yodkeeree S; Pyne SG; Limtrakul Dejkriengkraikul P
    Asian Pac J Cancer Prev; 2018 Dec; 19(12):3533-3543. PubMed ID: 30583680
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hydroxychloroquine reverses the drug resistance of leukemic K562/ADM cells by inhibiting autophagy.
    Wang F; Zhang Z; Leung WT; Chen J; Yi J; Ying C; Yuan M; Wang M; Zhang N; Qiu X; Wang L; Wei H
    Mol Med Rep; 2019 Oct; 20(4):3883-3892. PubMed ID: 31485616
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reversing Multidrug Resistance in Chemo-resistant Human Lung Adenocarcinoma (A549/DOX) Cells by Algerian Propolis Through Direct Inhibiting the P-gp Efflux-pump, G0/G1 Cell Cycle Arrest and Apoptosis Induction.
    Kebsa W; Lahouel M; Rouibah H; Zihlif M; Ahram M; Abu-Irmaileh B; Mustafa E; Al-Ameer HJ; Al Shhab M
    Anticancer Agents Med Chem; 2018; 18(9):1330-1337. PubMed ID: 30088453
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ailanthone reverses multidrug resistance by inhibiting the P-glycoprotein-mediated efflux in resistant K562/A02 cells.
    Han F; Liu G; Sun C; Wei J
    Cell Mol Biol (Noisy-le-grand); 2018 Dec; 64(15):55-61. PubMed ID: 30672437
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Modulation of multidrug resistant in cancer cells by EGCG, tannic acid and curcumin.
    Li H; Krstin S; Wink M
    Phytomedicine; 2018 Nov; 50():213-222. PubMed ID: 30466981
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Glabridin resensitizes p-glycoprotein-overexpressing multidrug-resistant cancer cells to conventional chemotherapeutic agents.
    Qian J; Xia M; Liu W; Li L; Yang J; Mei Y; Meng Q; Xie Y
    Eur J Pharmacol; 2019 Jun; 852():231-243. PubMed ID: 30959046
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Modulation of the spacer in N,N-bis(alkanol)amine aryl ester heterodimers led to the discovery of a series of highly potent P-glycoprotein-based multidrug resistance (MDR) modulators.
    Dei S; Braconi L; Trezza A; Menicatti M; Contino M; Coronnello M; Chiaramonte N; Manetti D; Perrone MG; Romanelli MN; Udomtanakunchai C; Colabufo NA; Bartolucci G; Spiga O; Salerno M; Teodori E
    Eur J Med Chem; 2019 Jun; 172():71-94. PubMed ID: 30947123
    [TBL] [Abstract][Full Text] [Related]  

  • 30. SLC25A40 Facilitates Anticancer Drug Resistance in Human Leukemia K562 Cells.
    Kudo N; Kouno R; Shibayama Y
    Biol Pharm Bull; 2023 Sep; 46(9):1304-1309. PubMed ID: 37407483
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Can P-glycoprotein mediate resistance to nilotinib in human leukaemia cells?
    Kosztyu P; Dolezel P; Mlejnek P
    Pharmacol Res; 2013 Jan; 67(1):79-83. PubMed ID: 23103446
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Metformin enhances doxorubicin sensitivity via inhibition of doxorubicin efflux in P-gp-overexpressing MCF-7 cells.
    Shafiei-Irannejad V; Samadi N; Yousefi B; Salehi R; Velaei K; Zarghami N
    Chem Biol Drug Des; 2018 Jan; 91(1):269-276. PubMed ID: 28782285
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sodium azulene sulfonate reverses multidrug resistance in K562/A02 cells.
    Wang Z; Zhou N; Zhao J; Zhang X
    Cell Mol Biol (Noisy-le-grand); 2019 Sep; 65(7):105-110. PubMed ID: 31880526
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Selection of P-Glycoprotein Inhibitor and Formulation of Combinational Nanoformulation Containing Selected Agent Curcumin and DOX for Reversal of Resistance in K562 Cells.
    Dash TK; Konkimalla VB
    Pharm Res; 2017 Aug; 34(8):1741-1750. PubMed ID: 28536971
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MicroRNA‑145 promotes the apoptosis of leukemic stem cells and enhances drug‑resistant K562/ADM cell sensitivity to adriamycin via the regulation of ABCE1.
    Wuxiao Z; Wang H; Su Q; Zhou H; Hu M; Tao S; Xu L; Chen Y; Hao X
    Int J Mol Med; 2020 Oct; 46(4):1289-1300. PubMed ID: 32945355
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Apoptosis sensitization by Euphorbia factor L1 in ABCB1-mediated multidrug resistant K562/ADR cells.
    Zhang JY; Lin MT; Yi T; Tang YN; Fan LL; He XC; Zhao ZZ; Chen HB
    Molecules; 2013 Oct; 18(10):12793-808. PubMed ID: 24135937
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of phosphatase and tensin homology deleted on chromosome 10 (PTEN) gene transfection on reversal of multidrug resistance in K562/ADM cells.
    Cheng Z; Yang N; Liang W; Yan X; Li L; Pan L
    Leuk Lymphoma; 2012 Jul; 53(7):1383-9. PubMed ID: 22185283
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rhein reverses doxorubicin resistance in SMMC-7721 liver cancer cells by inhibiting energy metabolism and inducing mitochondrial permeability transition pore opening.
    Wu L; Cao K; Ni Z; Wang S; Li W; Liu X; Chen Z
    Biofactors; 2019 Jan; 45(1):85-96. PubMed ID: 30496631
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Curcumin reverses doxorubicin resistance via inhibition the efflux function of ABCB4 in doxorubicin‑resistant breast cancer cells.
    Wen C; Fu L; Huang J; Dai Y; Wang B; Xu G; Wu L; Zhou H
    Mol Med Rep; 2019 Jun; 19(6):5162-5168. PubMed ID: 31059026
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Schizandrol A reverses multidrug resistance in resistant chronic myeloid leukemia cells K562/A02.
    Arken N
    Cell Mol Biol (Noisy-le-grand); 2019 Jan; 65(1):78-83. PubMed ID: 30782299
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.